(18)F-FDG PET/CT Scans Can Identify Sub-Groups of NSCLC Patients with High Glucose Uptake in the Majority of Their Tumor Lesions

Background: Reprogrammed glucose metabolism is a hallmark of cancer making it an attractive therapeutic target, especially in cancers with high glucose uptake such as non-small cell lung cancer (NSCLC). Tools to select patients with high glucose uptake in the majority of tumor lesions are essential...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Cancer
Egile Nagusiak: Hendriks, Anne M., Brouwers, Adrienne H., Giannopoulos, Panagiotis, Lefrandt, Joop D., Timens, Wim, Groen, Harry J.M., de Bock, Geertruida H., Jalving, Mathilde
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Ivyspring International Publisher 2021
Gaiak:
Research Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7738988/
https://ncbi.nlm.nih.gov/pubmed/33391452
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.45899
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak